Dr. Ale Berlin is a staff clinician-scientist and radiation oncologist at the Princess Margaret Cancer Center. He also serves as Medical Director of the Princess Margaret Cancer Digital Intelligence program. He completed his training in Chile, Israel, and Canada. His clinical practice focuses on the discovery and clinical evaluation of novel therapeutics capitalizing on genomic characterization genitourinary malignancies, molecular and MR imaging, and high-precision radiotherapy techniques. Dr. Berlin is a PI of the NRG GU010 study investigating the use of clinicogenomic risk stratification for treatment individualization in men with localized prostate cancer. Dr. Berlin also leads a clinical initiative quantifying the human and machine performance during the clinical deployment of an in-house developed AI radiotherapy planning method for prostate cancer.